PITTSBURGH--(BUSINESS WIRE)--The new name and branding for MEDRAD, INC.’s new interventional products division was unveiled to the public today at the 20th annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium, sponsored by the Cardiovascular Research Foundation, Oct. 12 – 17th in Washington D.C. Operating under the new name MEDRAD Interventional™/Possis®, the division combines a number of market-leading products such as the AngioJet® Thrombectomy System, the MEDRAD Avanta® Fluid Management Injector System, Mark V ProVis® Angiographic Injection System, and Fetch® Aspiration Catheter, among others.
